WebClick Tracer

A breakthrough in dermatology: Laura Verallo de Bertotto’s VMV Hypoallergenics chosen for Hidradenitis Suppurativa clinic trial

Staying at the forefront of medicine requires dedicated research, and it’s this passion for innovation that propels VMV Hypoallergenics ahead of its competitors.

VMV Hypoallergenics CEO Laura Verallo de Bertotto proudly announced that VMV Skin Research Centre + Clinics, located in Makati City, has been selected as a clinical trial site for Hidradenitis Suppurativa (HS), a painful skin condition impacting millions worldwide.

“Yay to our research clinic VMV Skin Research Centre + Clinics! Chosen again as a clinical trial site for HS (and I’m thrilled so much more research is going into this condition),” de Bertotto said.

VMV Hypoallergenics was founded by de Bertotto’s mother, Dr. Vermen M. Verallo-Rowell, a Filipina dermatologist who was among the first to conduct studies on virgin coconut oil and monolaurin for skin.

VMV Skin Research Centre also has an upcoming Phase IV clinical trial for psoriasis. The team and external experts have designed a program that provides researchers and site staff with information and training for a successful trial.

Milyonaryo | Latest News